Cargando…

Potential Role and Expression Level of Urinary CXCL8 in Different Stages of Incipient Diabetic Nephropathy with Undiminished Creatinine Clearance: A Pilot Study

BACKGROUND: Diabetic nephropathy (DN) is one of the most devastating microvascular complications of diabetes, with a high prevalence and poor prognosis. Early intervention is crucial to improve the outcomes of DN. CXCL8 is related to podocyte damage in incipient DN; however, the role and expression...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Yang, Li, Huili, Wang, Rui, Ma, Ning, Liu, Lianyuan, Shi, Rui, Zhang, Bohua, Lin, Ningning, Tian, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284165/
https://www.ncbi.nlm.nih.gov/pubmed/37351280
http://dx.doi.org/10.2147/DMSO.S410638
_version_ 1785061348599660544
author He, Yang
Li, Huili
Wang, Rui
Ma, Ning
Liu, Lianyuan
Shi, Rui
Zhang, Bohua
Lin, Ningning
Tian, Yiming
author_facet He, Yang
Li, Huili
Wang, Rui
Ma, Ning
Liu, Lianyuan
Shi, Rui
Zhang, Bohua
Lin, Ningning
Tian, Yiming
author_sort He, Yang
collection PubMed
description BACKGROUND: Diabetic nephropathy (DN) is one of the most devastating microvascular complications of diabetes, with a high prevalence and poor prognosis. Early intervention is crucial to improve the outcomes of DN. CXCL8 is related to podocyte damage in incipient DN; however, the role and expression level of CXCL8 have never been elucidated, especially in those with undiminished creatinine clearance. METHODS: Consecutive inpatients with type 2 diabetes were included in this study. Patients were assigned into four groups based on the Mogensen stage, reflecting pathological features through clinical manifestations: non-DN group, hyperfiltration group, microalbuminuria group and overt DN group. Clinical and laboratory data were retrospectively collected and analyzed. Urinary CXCL8 (uCXCL8) was measured using an enzyme-linked immunosorbent assay (ELISA) method and adjusted for urinary creatinine (Cr) from the same urine sample. RESULTS: In total, 88 eligible consecutive inpatients with type 2 diabetes were included in this study. uCXCL8 was differentially expressed in different stages of incipient DN; it decreased in the hyperfiltration phase of incipient DN (1.40±1.01 pg/μmol Cr) and was highly expressed in patients in the microalbuminuria stage (5.01±4.01 pg/μmol Cr). uCXCL8 was positively correlated with age, diabetes course, cystatin C and urinary albuminuria-to-creatinine ratio, but negatively correlated with estimated glomerular filtration rate (P<0.05). uCXCL8 was a risk factor for classic DN after adjusting for age, diabetes course and cystatin C (OR=1.17, 95% CI 0.98–1.4, P=0.045). CONCLUSION: CXCL8 played an important role in the progression of incipient DN. The unique expression profile of uCXCL8 may provide a reference for understanding the prognosis and mechanisms of incipient DN progression. uCXCL8 was an independent risk factor for the development of classic DN.
format Online
Article
Text
id pubmed-10284165
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-102841652023-06-22 Potential Role and Expression Level of Urinary CXCL8 in Different Stages of Incipient Diabetic Nephropathy with Undiminished Creatinine Clearance: A Pilot Study He, Yang Li, Huili Wang, Rui Ma, Ning Liu, Lianyuan Shi, Rui Zhang, Bohua Lin, Ningning Tian, Yiming Diabetes Metab Syndr Obes Original Research BACKGROUND: Diabetic nephropathy (DN) is one of the most devastating microvascular complications of diabetes, with a high prevalence and poor prognosis. Early intervention is crucial to improve the outcomes of DN. CXCL8 is related to podocyte damage in incipient DN; however, the role and expression level of CXCL8 have never been elucidated, especially in those with undiminished creatinine clearance. METHODS: Consecutive inpatients with type 2 diabetes were included in this study. Patients were assigned into four groups based on the Mogensen stage, reflecting pathological features through clinical manifestations: non-DN group, hyperfiltration group, microalbuminuria group and overt DN group. Clinical and laboratory data were retrospectively collected and analyzed. Urinary CXCL8 (uCXCL8) was measured using an enzyme-linked immunosorbent assay (ELISA) method and adjusted for urinary creatinine (Cr) from the same urine sample. RESULTS: In total, 88 eligible consecutive inpatients with type 2 diabetes were included in this study. uCXCL8 was differentially expressed in different stages of incipient DN; it decreased in the hyperfiltration phase of incipient DN (1.40±1.01 pg/μmol Cr) and was highly expressed in patients in the microalbuminuria stage (5.01±4.01 pg/μmol Cr). uCXCL8 was positively correlated with age, diabetes course, cystatin C and urinary albuminuria-to-creatinine ratio, but negatively correlated with estimated glomerular filtration rate (P<0.05). uCXCL8 was a risk factor for classic DN after adjusting for age, diabetes course and cystatin C (OR=1.17, 95% CI 0.98–1.4, P=0.045). CONCLUSION: CXCL8 played an important role in the progression of incipient DN. The unique expression profile of uCXCL8 may provide a reference for understanding the prognosis and mechanisms of incipient DN progression. uCXCL8 was an independent risk factor for the development of classic DN. Dove 2023-06-17 /pmc/articles/PMC10284165/ /pubmed/37351280 http://dx.doi.org/10.2147/DMSO.S410638 Text en © 2023 He et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
He, Yang
Li, Huili
Wang, Rui
Ma, Ning
Liu, Lianyuan
Shi, Rui
Zhang, Bohua
Lin, Ningning
Tian, Yiming
Potential Role and Expression Level of Urinary CXCL8 in Different Stages of Incipient Diabetic Nephropathy with Undiminished Creatinine Clearance: A Pilot Study
title Potential Role and Expression Level of Urinary CXCL8 in Different Stages of Incipient Diabetic Nephropathy with Undiminished Creatinine Clearance: A Pilot Study
title_full Potential Role and Expression Level of Urinary CXCL8 in Different Stages of Incipient Diabetic Nephropathy with Undiminished Creatinine Clearance: A Pilot Study
title_fullStr Potential Role and Expression Level of Urinary CXCL8 in Different Stages of Incipient Diabetic Nephropathy with Undiminished Creatinine Clearance: A Pilot Study
title_full_unstemmed Potential Role and Expression Level of Urinary CXCL8 in Different Stages of Incipient Diabetic Nephropathy with Undiminished Creatinine Clearance: A Pilot Study
title_short Potential Role and Expression Level of Urinary CXCL8 in Different Stages of Incipient Diabetic Nephropathy with Undiminished Creatinine Clearance: A Pilot Study
title_sort potential role and expression level of urinary cxcl8 in different stages of incipient diabetic nephropathy with undiminished creatinine clearance: a pilot study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284165/
https://www.ncbi.nlm.nih.gov/pubmed/37351280
http://dx.doi.org/10.2147/DMSO.S410638
work_keys_str_mv AT heyang potentialroleandexpressionlevelofurinarycxcl8indifferentstagesofincipientdiabeticnephropathywithundiminishedcreatinineclearanceapilotstudy
AT lihuili potentialroleandexpressionlevelofurinarycxcl8indifferentstagesofincipientdiabeticnephropathywithundiminishedcreatinineclearanceapilotstudy
AT wangrui potentialroleandexpressionlevelofurinarycxcl8indifferentstagesofincipientdiabeticnephropathywithundiminishedcreatinineclearanceapilotstudy
AT maning potentialroleandexpressionlevelofurinarycxcl8indifferentstagesofincipientdiabeticnephropathywithundiminishedcreatinineclearanceapilotstudy
AT liulianyuan potentialroleandexpressionlevelofurinarycxcl8indifferentstagesofincipientdiabeticnephropathywithundiminishedcreatinineclearanceapilotstudy
AT shirui potentialroleandexpressionlevelofurinarycxcl8indifferentstagesofincipientdiabeticnephropathywithundiminishedcreatinineclearanceapilotstudy
AT zhangbohua potentialroleandexpressionlevelofurinarycxcl8indifferentstagesofincipientdiabeticnephropathywithundiminishedcreatinineclearanceapilotstudy
AT linningning potentialroleandexpressionlevelofurinarycxcl8indifferentstagesofincipientdiabeticnephropathywithundiminishedcreatinineclearanceapilotstudy
AT tianyiming potentialroleandexpressionlevelofurinarycxcl8indifferentstagesofincipientdiabeticnephropathywithundiminishedcreatinineclearanceapilotstudy